A-Alpha Bio alternatives and competitors
The closest alternatives to A-Alpha Bio are Absci, Nabla Bio, BigHat Biosciences and LabGenius.
A-Alpha Bio measures how proteins bind to each other at very large scale and trains antibody design models on the results. AlphaSeq is its laboratory method, with more than a billion binding measurements by the company's count. AlphaBind is the set of models trained on that data to predict binding from a protein's sequence.
The alternatives all design antibodies with AI. They differ in where they start, which targets they pursue and how a customer buys.
8 alternatives to A-Alpha Bio
What each product does, with its price as the vendor publishes it.
-
A
Generative design with its own lab
Absci pairs Origin-1, a generative model that designs antibodies against a chosen epitope, with a wet lab that produces billions of protein interaction measurements a week to retrain its models. It develops antibodies as its own medicines and with partners.
Price: No published price
-
N
Membrane protein targets
Nabla Bio designs antibodies for targets embedded in the cell membrane, such as G protein coupled receptors, ion channels and transporters. Its JAM platform generates designs and scores how likely each is to survive an experiment, and Nabla makes and tests them in its own lab.
Price: No published price
-
B
Improves an existing molecule
BigHat Biosciences starts from an existing antibody, its own or a partner's, and improves it in rounds. Its machine learning is tied to Milliner, an automated wet lab, so each round of designs is built and measured before the next.
Price: No published price
-
L
Cancer antibodies from a robotic lab
LabGenius designs antibody drugs for cancer. Its EVA engine proposes antibodies that improve several properties at once, builds and tests them in automated cycles, and learns from the results.
Price: No published price
-
C
Licenses the design models
Chai Discovery licenses foundation models for molecular design to research organizations and does not build its own pipeline. Chai-2 designs antibodies and miniproteins from a target and epitope prompt, and Chai-1, its structure prediction model, has open weights.
Price: No published price
-
B
Antibodies that do more than block
Biolojic Design designs agonists, antagonists, conditional binders and multibodies, which are single antibodies that bind more than one target on the same arm. AU-007, an antibody designed on its platform, has entered a human trial.
Price: No published price
-
A
Antibodies for receptors and ion channels
Antiverse generates antibody and nanobody sequences from the target sequence alone, aimed at G protein coupled receptors, ion channels and other membrane proteins. Candidates are screened in human cell lines engineered to carry the receptor in its natural membrane setting.
Price: No published price
-
A
Self serve sequence design
Abtique, from EVQLV, takes a named target and returns candidate antibody sequences in about two weeks, with independent laboratory validation. A customer can start from the site without a sales call, and the site carries a pricing page.
Price: Priced, self serve
A-Alpha Bio alternatives, answered
What are the best alternatives to A-Alpha Bio?
Absci, Nabla Bio, BigHat Biosciences and LabGenius are the closest alternatives to A-Alpha Bio. Each designs antibodies with AI and tests them in its own lab. Chai Discovery licenses design models, and Abtique sells sequence design as a self serve service.
What makes A-Alpha Bio different?
Its starting point is measurement. AlphaSeq measures protein to protein interactions by the million, and the AlphaBind models are trained on that data. The designs AlphaBind proposes are then measured on AlphaSeq to check and sharpen the models.